Revive Therapeutics Ltd.
RVV
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.10K | 9.40K | 15.00K | 10.70K | 32.30K |
| Total Receivables | 49.90K | 28.70K | 4.50K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 41.00K | 48.60K | 54.60K | 32.20K | 38.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.20K | 7.30K | 7.20K | 7.30K | 7.00K |
| Total Current Assets | 107.20K | 94.00K | 81.30K | 50.20K | 77.80K |
|
|
|||||
| Total Current Assets | 107.20K | 94.00K | 81.30K | 50.20K | 77.80K |
| Net Property, Plant & Equipment | 500.00 | 500.00 | 600.00 | 600.00 | 600.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 6.52M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 202.40K | 190.60K | 179.30K | 150.30K | 6.70M |
|
|
|||||
| Total Accounts Payable | 2.38M | 2.20M | 1.98M | 1.94M | 1.88M |
| Total Accrued Expenses | 600.80K | 612.70K | 601.90K | 635.10K | 577.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.98M | 2.81M | 2.59M | 2.58M | 2.46M |
|
|
|||||
| Total Current Liabilities | 2.98M | 2.81M | 2.59M | 2.58M | 2.46M |
| Long-Term Debt | 50.80K | 50.70K | 48.90K | 49.00K | 45.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 58.20K | 58.30K | 58.10K | 58.40K | 57.70K |
| Total Liabilities | 3.09M | 2.92M | 2.69M | 2.68M | 2.56M |
|
|
|||||
| Common Stock & APIC | 52.90M | 52.18M | 51.36M | 52.30M | 49.49M |
| Retained Earnings | -56.18M | -56.68M | -55.62M | -56.60M | -47.03M |
| Treasury Stock & Other | 395.30K | 1.78M | 1.75M | 1.77M | 1.68M |
| Total Common Equity | -2.89M | -2.73M | -2.51M | -2.53M | 4.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.89M | -2.73M | -2.51M | -2.53M | 4.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.89M | -2.73M | -2.51M | -2.53M | 4.13M |
|
|
|||||